Jeremy L. Warner, MD, on the Clinical Impact of COVID-19 on Patients With Cancer

June 16, 2020 By The ASCO Post Staff

Jeremy L. Warner, MD, of Vanderbilt-Ingram Cancer Center, discusses data from the COVID-19 and Cancer Consortium cohort study, which included patients with active or prior hematologic or invasive solid malignancies, reported across academic and community sites (Abstract LBA110).

Related Content